台灣臨床試驗主持人資料庫|TPIDB

問卷

Log In

繁中 EN

TPIDB

TPIDB Outstanding PI

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberEX6018-4758

Active

2021-09-01 - 2027-03-31

Phase III

Recruiting11

ICD-10I70.0

Atherosclerosis of aorta

ICD-9440.0

Atherosclerosis of aorta

Trial Applicant

NOVO NORDISK PHARMA (TAIWAN) LTD.
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2026/04/01

Investigators and Locations

Principal Investigator Shih-Hsien Sung 無

Taipei Veterans General Hospital

Co-Principal Investigator

Tse-Min Lu 未分科
吳承學未分科
Hao-min Cheng 未分科
張俊欽未分科
黃偉銘未分科
Wen-Chung Yu 未分科
黃少嵩未分科

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tzung-Dau Wang 無

National Taiwan University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ting-Hsing Chao 無

National Taiwan University Hospital

Co-Principal Investigator

Po-Sheng Chen 未分科
Cheng-Han Lee 未分科
陳柏偉未分科
林志展未分科
Po-Tseng Lee 未分科
Ju-Yi Chen 未分科
李文煌未分科

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-Chang Hsieh Division of Cardiovascular Diseases

Linkou Chang Gung Medical Foundation

Co-Principal Investigator

陳東藝 Division of Cardiovascular Diseases
王朝永 Division of Cardiovascular Diseases
陳俊吉 Division of Cardiovascular Diseases
謝明哲 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 劉銘恩 Division of Cardiovascular Diseases

Hsinchu Mackay Memorial Hospital

Co-Principal Investigator

林柏霖 Division of Cardiovascular Diseases
吳敘平 Division of Cardiovascular Diseases
賴堯暉 Division of Cardiovascular Diseases
楊翔惟 Division of Cardiovascular Diseases
劉俞旻 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 曹玄明 Division of Cardiovascular Diseases

國立陽明交通大學附設醫院

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Zhih-Cherng Chen Division of Cardiovascular Diseases

Chi Mei Medical Center

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsung-Hsien Lin Division of Cardiovascular Diseases

Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 張鴻猷 Division of Cardiovascular Diseases

Cheng Hsin General Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Hsi-Hsien Chen Division of Nephrology

Taipei Medical University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 李統立 Division of Cardiovascular Diseases

E-DA Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

Taiwan

100-120 participants
Global

6200 participants